| Business Summary | | BioImmune,
Inc.,
formerly
known
as
CancerOption.com,
Inc.,
is
a
developmental
stage
company
with
a
Website
(www.CancerOption.com)
that
provides
educational
information
on
different
forms
of
cancer
being
researched,
targeting
specific
cancers
with
guidelines
and
products
for
alternative
and
adjunctive
therapies.
These
therapies
include
a
recommended
diet,
nutritional
supplements,
lifestyle
maintenance
and
post-remission
regimens.
BioImmune,
also
features
the
latest
research
and
statistics
on
cancer
treatments
and
immunological
disorders
including
traditional
and
alternative
therapies.
The
Company
provides
links
with
cancer
clinics
and
physicians,
as
well
as
links
to
Websites
and
medical
universities
for
educational
purposes.
The
Company
also
provides
books
on
cancer,
health,
immunological
disorders
and
general
health,
an
online
newsletter
and
various
products
related
to
cancer
treatments. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BioImmune,
Inc.
is
a
cancer
specific
health
care
portal
designed
to
provide
proprietary,
credible
and
reliable
cancer
and
prevention
information
to
cancer
patients,
cancer
survivors,
family
members,
physicians
and
the
general
public.
For
the
nine
months
ended
9/30/99,
revenues
totaled
$1
thousand,
up
from
$0.
Net
loss
totaled
$182
thousand,
up
from
$52
thousand.
Results
reflect
initial
service
revenues,
offset
by
increased
general
and
administrative
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | | Arnold
Takemoto,
Pres./CEO Michael
Quel,
CFO. | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|